Download video

Itacitinib and corticosteroids for chronic GvHD

76 views

GvHD Hub

2 years ago

Itacitinib and corticosteroids for chronic GvHD

Itacitinib and corticosteroids for chronic GvHD

Itacitinib and corticosteroids for chronic GvHD
7:37
Itacitinib and corticosteroids for chronic GvHD
by GvHD Hub
Itacitinib Clinical Trials for Chronic and Acute GVHD
3:12
Itacitinib Clinical Trials for Chronic and Acute GVHD
by OncLive
Clinical Trials of Itacitinib for Chronic and Acute GVHD
2:55
Clinical Trials of Itacitinib for Chronic and Acute GVHD
by OncLive
Effective treatment of low risk acute GVHD with itacitinib monotherapy
2:29
Effective treatment of low risk acute GVHD with itacitinib monotherapy
by ecancer
The safety and efficacy of itacitinib monotherapy for patients with low-risk GvHD
1:21
The safety and efficacy of itacitinib monotherapy for patients with low-risk GvHD
by VJHemOnc – Video Journal of Hematology \& HemOnc
Itacitinib for the prophylaxis of GvHD and CRS in T-cell replete haploidentical PBSCT
2:20
Itacitinib for the prophylaxis of GvHD and CRS in T-cell replete haploidentical PBSCT
by VJHemOnc – Video Journal of Hematology \& HemOnc
Itacitinib in patients with acute GvHD
3:55
Itacitinib in patients with acute GvHD
by VJHemOnc – Video Journal of Hematology \& HemOnc
Ruxolitinib: Treatment of Steroid-Refractory Acute GVHD
2:42
Ruxolitinib: Treatment of Steroid-Refractory Acute GVHD
by OncLive
Completed Clinical Trials of JAK Inhibitors for Treatment of Acute GVHD: Itacitinib \& Ruxolitinib
11:11
Completed Clinical Trials of JAK Inhibitors for Treatment of Acute GVHD: Itacitinib \& Ruxolitinib
by MedEdOTG
What is the latest update on the GRAVITAS-309 trial?
3:52
What is the latest update on the GRAVITAS-309 trial?
by GvHD Hub
How might itacitinib prophylaxis impact haplo-HSCT outcomes in the future?
7:50
How might itacitinib prophylaxis impact haplo-HSCT outcomes in the future?
by GvHD Hub
Case 3: Ruxolitinib for Steroid-Refractory Acute GVHD
4:03
Case 3: Ruxolitinib for Steroid-Refractory Acute GVHD
by Targeted Oncology
New Perspectives in Acute and Chronic GVHD
53:07
New Perspectives in Acute and Chronic GVHD
by PeerView Oncology
Phase II trial-in-progress of itacitinib in patients with myelofibrosis
1:49
Phase II trial-in-progress of itacitinib in patients with myelofibrosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
Targeting T-cell, B-cell \& APC activation to treat chronic GvHD
3:30
Targeting T-cell, B-cell \& APC activation to treat chronic GvHD
by VJHemOnc – Video Journal of Hematology \& HemOnc
Ruxolitinib for Steroid-Refractory Acute GVHD
4:23
Ruxolitinib for Steroid-Refractory Acute GVHD
by OncLive
Biomarkers for Graft-Versus-Host Disease: Biomarkers and Alternatives to Corticosteroid Treatment
3:28
Biomarkers for Graft-Versus-Host Disease: Biomarkers and Alternatives to Corticosteroid Treatment
by Managed Healthcare Executive
What is GvHD or Graft vs Host Disease| 5 Facts on GvHD
0:15
What is GvHD or Graft vs Host Disease| 5 Facts on GvHD
by PatientsEngage
Overcoming the Challenges of Acute and Chronic GVHD
56:36
Overcoming the Challenges of Acute and Chronic GVHD
by PeerView Oncology
Current and emerging treatment approaches for steroid-refractory acute \& chronic GvHD
5:23
Current and emerging treatment approaches for steroid-refractory acute \& chronic GvHD
by VJHemOnc – Video Journal of Hematology \& HemOnc